Literature DB >> 3395815

Pulmonary complications after subtotal oesophagectomy.

M Nishi1, Y Hiramatsu, K Hioki, T Hatano, M Yamamoto.   

Abstract

The postoperative pulmonary complications in 25 patients undergoing subtotal oesophagectomy for intrathoracic oesophageal carcinoma during the 3-year period 1981-1983 were compared with those of 25 patients undergoing surgery from 1984 to 1986. Although more extensive lymphadenectomies were performed from 1984, the mortality rate caused by the postoperative pulmonary complications was zero in the later period (1984-1986) compared with a rate of 16 per cent in the earlier period (1981-1983). The incidence of postoperative pulmonary complications was lower in the later series but the difference was not statistically significant. Factors which may have contributed to the decrease in critical pulmonary complications after surgery during the later period were the selection of the posterior mediastinal route for reconstruction, the introduction of selective endobronchial intubation by a double lumen tube with combined epidural anaesthesia, fluid restriction during and after surgery, postoperative mobilization and the administration of an expectorant.

Entities:  

Mesh:

Year:  1988        PMID: 3395815     DOI: 10.1002/bjs.1800750608

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  11 in total

1.  Intratracheal long-term pH monitoring: a new method to evaluate episodes of silent acid aspiration in patients after esophagectomy and gastric pull up.

Authors:  Werner K H Kauer; Hubert J Stein; Holger Bartels; J Rüdiger Siewert
Journal:  J Gastrointest Surg       Date:  2003 Jul-Aug       Impact factor: 3.452

2.  Preoperative assessment of cervical lymph node involvement in esophageal cancer.

Authors:  T Saito; A Kuwahara; K Kaketani; E Hirao; M Miyahara; K Shimoda; M Kobayashi
Journal:  Jpn J Surg       Date:  1991-03

3.  The treatment of lymph node metastasis from esophageal cancer by extensive lymphadenectomy.

Authors:  K Isono; T Ochiai; K Okuyama; S Onoda
Journal:  Jpn J Surg       Date:  1990-03

4.  Pulmonary complications in patients with chronic obstructive pulmonary disease following transthoracic esophagectomy.

Authors:  Wen-Jie Jiao; Tian-You Wang; Min Gong; Hao Pan; Yan-Bing Liu; Zhi-Hua Liu
Journal:  World J Gastroenterol       Date:  2006-04-28       Impact factor: 5.742

5.  Surgical treatment for poor-risk patients with carcinoma of the esophagus.

Authors:  H Yamanaka; Y Hiramatsu; Y Kawaguchi; Y Kojima; K Hioki; M Yamamoto
Journal:  Jpn J Surg       Date:  1991-03

6.  Ventilatory and intensive care requirements following oesophageal resection.

Authors:  S A Robertson; R J E Skipworth; D L Clarke; T J Crofts; A Lee; A C de Beaux; S Paterson-Brown
Journal:  Ann R Coll Surg Engl       Date:  2006-07       Impact factor: 1.891

7.  Predictive factors for postoperative pulmonary complications and mortality after esophagectomy for cancer.

Authors:  Simon Law; Kam-Ho Wong; Ka-Fai Kwok; Kent-Man Chu; John Wong
Journal:  Ann Surg       Date:  2004-11       Impact factor: 12.969

8.  Risk analysis in resection of squamous cell carcinoma of the esophagus.

Authors:  S Y Law; M Fok; J Wong
Journal:  World J Surg       Date:  1994 May-Jun       Impact factor: 3.352

9.  Perioperative granulocyte colony-stimulating factor does not prevent severe infections in patients undergoing esophagectomy for esophageal cancer: a randomized placebo-controlled clinical trial.

Authors:  Hartmut Schaefer; Andreas Engert; Guido Grass; Georg Mansmann; Gernot Wassmer; Kai Hubel; Dietrich Loehlein; Bernward C Ulrich; Hans Lippert; Wolfram T Knoefel; Arnulf H Hoelscher
Journal:  Ann Surg       Date:  2004-07       Impact factor: 12.969

10.  Association of level of anastomosis and anastomotic leak after esophagectomy in anterior mediastinal reconstruction.

Authors:  Katsunori Nishikawa; Tetsuji Fujita; Yako Hasegawa; Yujiro Tanaka; Akira Matsumoto; Norio Mitsumori; Katsuhiko Yanaga
Journal:  Esophagus       Date:  2018-05-31       Impact factor: 4.230

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.